Principal Financial Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.5K Buy
+10,141
New +$91.9K ﹤0.01% 2130
2025
Q4
Sell
-11,386
Closed -$98.7K 2242
2025
Q3
$98.7K Buy
11,386
+806
+8% +$6.27K ﹤0.01% 2194
2025
Q2
$66.7K Sell
10,580
-1,333
-11% -$8.83K ﹤0.01% 2183
2025
Q1
$76.4K Sell
11,913
-274
-2% -$2.27K ﹤0.01% 2111
2024
Q4
$98K Sell
12,187
-232
-2% -$2.24K ﹤0.01% 2151
2024
Q3
$157K Sell
12,419
-11,178
-47% -$144K ﹤0.01% 2122
2024
Q2
$299K Sell
23,597
-3,090
-12% -$31.1K ﹤0.01% 2057
2024
Q1
$128K Buy
26,687
+1,966
+8% +$9.12K ﹤0.01% 2248
2023
Q4
$119K Buy
24,721
+1,219
+5% +$7.46K ﹤0.01% 2245
2023
Q3
$170K Buy
23,502
+71
+0.3% +$567 ﹤0.01% 2191
2023
Q2
$174K Buy
23,431
+3,422
+17% +$26.9K ﹤0.01% 2203
2023
Q1
$139K Sell
20,009
-1,856
-8% -$17.1K ﹤0.01% 2242
2022
Q4
$225K Buy
21,865
+3,942
+22% +$69.6K ﹤0.01% 2169
2022
Q3
$326K Sell
17,923
-1,396
-7% -$60.5K ﹤0.01% 2061
2022
Q2
$994K Buy
19,319
+1,530
+9% +$79.3K ﹤0.01% 1920
2022
Q1
$1.31M Sell
17,789
-1,045
-6% -$93.2K ﹤0.01% 1930
2021
Q4
$2.69M Sell
18,834
-27,815
-60% -$4.78M ﹤0.01% 1815
2021
Q3
$9.67M Buy
46,649
+22,033
+90% +$4.86M 0.01% 1416
2021
Q2
$5.23M Buy
24,616
+2,745
+13% +$503K ﹤0.01% 1700
2021
Q1
$3.96M Buy
21,871
+2,148
+11% +$428K ﹤0.01% 1728
2020
Q4
$2.2M Buy
19,723
+4,527
+30% +$481K ﹤0.01% 1782
2020
Q3
$1.65M Sell
15,196
-1,832
-11% -$223K ﹤0.01% 1771
2020
Q2
$1.42M Buy
+17,028
New +$651K ﹤0.01% 1759
2019
Q2
Sell
-5,164
Closed -$57K 2256
2019
Q1
$57K Buy
5,164
+65
+1% +$2.05K ﹤0.01% 2180
2018
Q4
$188K Sell
5,099
-152
-3% -$5.89K ﹤0.01% 2138
2018
Q3
$197K Buy
5,251
+247
+5% +$6.96K ﹤0.01% 2175
2018
Q2
$135K Buy
5,004
+233
+5% +$7.88K ﹤0.01% 2203
2018
Q1
$200K Buy
4,771
+392
+9% +$15.7K ﹤0.01% 2110
2017
Q4
$109K Buy
4,379
+2,405
+122% +$58.7K ﹤0.01% 2180
2017
Q3
$45K Sell
1,974
-383
-16% -$8.57K ﹤0.01% 2187
2017
Q2
$54K Sell
2,357
-48
-2% -$942 ﹤0.01% 2228
2017
Q1
$62K Hold
2,405
﹤0.01% 2168
2016
Q4
$61K Hold
2,405
﹤0.01% 2189
2016
Q3
$100K Buy
2,405
+27
+1% +$3.49K ﹤0.01% 2101
2016
Q2
$346K Buy
2,378
+22
+0.9% +$2.52K ﹤0.01% 1907
2016
Q1
$243K Buy
2,356
+36
+2% +$3.86K ﹤0.01% 1977
2015
Q4
$389K Buy
2,320
+17
+0.7% +$2.62K ﹤0.01% 1895
2015
Q3
$326K Sell
2,303
-8
-0.3% -$1.79K ﹤0.01% 1934
2015
Q2
$515K Buy
2,311
+414
+22% +$72.8K ﹤0.01% 1874
2015
Q1
$314K Sell
1,897
-25
-1% -$4.06K ﹤0.01% 1907
2014
Q4
$228K Sell
1,922
-616
-24% -$64.4K ﹤0.01% 2008
2014
Q3
$212K Buy
2,538
+363
+17% +$32.8K ﹤0.01% 2018
2014
Q2
$201K Sell
2,175
-406
-16% -$35.7K ﹤0.01% 2090
2014
Q1
$234K Sell
2,581
-24
-0.9% -$2.68K ﹤0.01% 2085
2013
Q4
$267K Buy
+2,605
New +$184K ﹤0.01% 2051
2013
Q3
Sell
-3,544
Closed -$145K 2286
2013
Q2
$145K Buy
+3,544
New +$154K ﹤0.01% 2151

Other funds holding NVAX

Principal Financial Group's NVAX Position: Q1 2026 in Review

Principal Financial Group opened a new position in Novavax (NVAX) in Q1 2026: 10,141 shares worth $82.5K. The stake represents ﹤0.01% of the portfolio and ranks #2130 among its holdings. This is a return to the name: Principal Financial Group previously reported a position in NVAX as recently as Q3 2025.

Principal Financial Group first reported a position in NVAX in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.67M in Q3 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Principal Financial Group held 10,141 shares of Novavax worth $82.5K as of Q1 2026.
  • Novavax was a new Principal Financial Group position in Q1 2026.
  • Novavax made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2130 holding.
  • Principal Financial Group first reported a position in Novavax in Q2 2013 and has held it in 46 quarters since.
  • Principal Financial Group's Novavax position peaked at $9.67M in Q3 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.